Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer
Year: 2013
Type: article
Source: Cancer
DOI: 10.1002/cncr.28283
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1610065887
